PI-RADS version 2: what you need to know(☆)

Por Barrett, T., Turkbey, B., Choyke, P.L.
Publicado no Clin Radiol (2015)

Fluorescent Molecular Imaging: Technical Progress and Current Preclinical and Clinical Applications in Urogynecologic Diseases

Por Alexander, V.M., Choyke, P.L., Kobayashi, H.
Publicado no Curr Mol Med (2013)

Infected aortic aneurysms. A changing entity.

Por Gomes, M N, Choyke, P L, Wallace, R B
Publicado em 1992

Molecular imaging in myeloma precursor disease

Por Mena, E, Choyke, P, Tan, E, Landgren, O, Kurdziel, K
Publicado em 2011

Recent Advances in Optical Cancer Imaging of EGF Receptors

Por Kramer-Marek, G., Longmire, M. R., Choyke, P. L., Kobayashi, H.
Publicado no Curr Med Chem (2012)

Functional and Molecular Imaging: Applications for Diagnosis and Staging of Localised Prostate Cancer

Por Turkbey, B., Mena, E., Aras, O., Garvey, B., Grant, K., Choyke, P.L.
Publicado no Clin Oncol (R Coll Radiol) (2013)

Comparing nonrigid registration techniques for motion corrected MR prostate diffusion imaging

Por Buerger, C., Sénégas, J., Kabus, S., Carolus, H., Schulz, H., Agarwal, H., Turkbey, B., Choyke, P. L., Renisch, S.
Publicado no Med Phys (2015)

Mosaicism in von Hippel–Lindau Disease: Lessons from Kindreds with Germline Mutations Identified in Offspring with Mosaic Parents

Por Sgambati, M. T., Stolle, C., Choyke, P. L., Walther, M. M., Zbar, B., Linehan, W. M., Glenn, G. M.
Publicado em 2000

Synthesis and characterization of ultra-small superparamagnetic iron oxide nanoparticles thinly coated with silica

Por Bumb, A, Brechbiel, M W, Choyke, P L, Fugger, L, Eggeman, A, Prabhakaran, D, Hutchinson, J, Dobson, P J
Publicado em 2008

Preclinical evaluation of a monoclonal antibody (3C6) specific for prostate-specific membrane antigen

Por Regino, C.A.S., Wong, K.J., Milenic, D.E., Holmes, E.H., Garmestani, K., Choyke, P.L., Brechbiel, M.W.
Publicado em 2009

Preparation and Characterization of a Magnetic and Optical Dual-Modality Molecular Probe

Por Bumb, A, Regino, C A S, Perkins, M R, Bernardo, M, Ogawa, M, Fugger, L, Choyke, P L, Dobson, P J, Brechbiel, M W
Publicado em 2010

PSMA PET/CT with Glu-urea-Lys-(Ahx)-[(68)Ga(HBED-CC)] versus 3D CT volumetric lymph node assessment in recurrent prostate cancer

Por Giesel, Frederik L., Fiedler, H., Stefanova, M., Sterzing, F., Rius, M., Kopka, K., Moltz, J. H., Afshar-Oromieh, A., Choyke, P. L., Haberkorn, U., Kratochwil, C.
Publicado no Eur J Nucl Med Mol Imaging (2015)

Genetic flanking markers refine diagnostic criteria and provide insights into the genetics of Von Hippel Lindau disease.

Por Seizinger, B R, Smith, D I, Filling-Katz, M R, Neumann, H, Green, J S, Choyke, P L, Anderson, K M, Freiman, R N, Klauck, S M, Whaley, J
Publicado em 1991

IMAGE FUSION USING CT, MRI AND PET FOR TREATMENT PLANNING, NAVIGATION AND FOLLOW UP IN PERCUTANEOUS RFA

Por Giesel, F.L., Mehndiratta, A., Locklin, J., McAuliffe, M.J., White, S., Choyke, P.L., Knopp, M.V., Wood, B.J., Haberkorn, U., von Tengg-Kobligk, H.
Publicado em 2009

Impact of Primary Staging with Fibroblast Activation Protein Specific Enzyme Inhibitor (FAPI)-PET/CT on Radio-Oncologic Treatment Planning of Patients with Esophageal Cancer

Por Ristau, J., Giesel, F. L., Haefner, M. F., Staudinger, F., Lindner, T., Merkel, A., Schlittenhardt, J., Kratochwil, C., Choyke, P. L., Herfarth, K., Debus, J., Haberkorn, U., Koerber, S. A.
Publicado no Mol Imaging Biol (2020)

Effect of Chelator Conjugation Level and Injection Dose on Tumor and Organ Uptake of (111)In Labeled MORAb-009, an Anti-mesothelin Antibody

Por Shin, I. S., Lee, S.-M., Kim, H. S., Yao, Z., Regino, C., Sato, N., Cheng, K. T., Hassan, R., Campo, M. F., Albone, E. F., Choyke, P. L., Pastan, I., Paik, C. H.
Publicado em 2011

BHD mutations, clinical and molecular genetic investigations of Birt–Hogg–Dubé syndrome: a new series of 50 families and a review of published reports

Por Toro, J R, Wei, M-H, Glenn, G M, Weinreich, M, Toure, O, Vocke, C, Turner, M, Choyke, P, Merino, M J, Pinto, P A, Steinberg, S M, Schmidt, L S, Linehan, W M
Publicado em 2008

A phase II study of TRC105 in patients with hepatocellular carcinoma who have progressed on sorafenib

Por Duffy, AG, Ulahannan, SV, Cao, L, Rahma, OE, Makarova-Rusher, OV, Kleiner, DE, Fioravanti, S, Walker, M, Carey, S, Yu, Y, Venkatesan, AM, Turkbey, B, Choyke, P, Trepel, J, Bollen, KC, Steinberg, SM, Figg, WD, Greten, TF
Publicado no United European Gastroenterol J (2015)

Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer

Por Wei, M‐H, Toure, O, Glenn, G M, Pithukpakorn, M, Neckers, L, Stolle, C, Choyke, P, Grubb, R, Middelton, L, Turner, M L, Walther, M M, Merino, M J, Zbar, B, Linehan, W M, Toro, J R
Publicado em 2006

ANG1005 for breast cancer brain metastases: correlation between (18)F-FLT-PET after first cycle and MRI in response assessment

Por O’Sullivan, C. C., Lindenberg, M., Bryla, C., Patronas, N., Peer, C. J., Amiri-Kordestani, L., Davarpanah, N., Gonzalez, E. M., Burotto, M., Choyke, P., Steinberg, S. M., Liewehr, D. J., Figg, W. D., Fojo, T., Balasubramaniam, S., Bates, S. E.
Publicado no Breast Cancer Res Treat (2016)